Your search did not match any results.
We suggest you try the following to help find what you’re looking for:
Learn how innovative machine learning techniques are showing great promise in helping life science companies identify and rectify systemic inefficiencies.
Read the blogBy transitioning to a solution used by all CROs across the portfolio, oversight improves, and sponsors can build reliable institutional knowledge about CRO performance.
Read the blogOracle and Cognizant are integrating technologies in a move designed to help hasten trial launches, and get promising new treatments to market faster.
Read the articleQ&A with Oracle Health Sciences’ GM Henry McNamara on the recent Oracle-Informa research and how COVID-19 has impacted how the industry views decentralized clinical trials.
Read the articleThe pandemic has created a lot of disruption in clinical trials, but not all of it has been negative.
Read the blogExisting regulations remain in place that can make it difficult to actually design and run a decentralized clinical trial.
Read the blogThe application of AI to disease management and treatment is rapidly evolving and providing itself invaluable, one therapeutic area that has quickly demonstrated benefits from the application is infectious disease.
Read the blogAs the industry focuses their efforts to improve study startup, stakeholders are reaching out to providers well-versed in the intricacies of study startup, who have a proven track record.
Read the blogLearn about the collaboration between Cognizant and Oracle that eliminates redundancy for sites and delivers better outcomes for sponsors and CROs.
Read the blogLeaders in clinical research are working hard to synthesize what 2020 brought us and apply learnings to 2021.
Read the articleHow much has the COVID-19 pandemic accelerated the evolution of clinical trials? A new report from Oracle Health Sciences and Informa Pharma Intelligence attempts to answer that question.
Read the articleSponsors and trial designers can be vexed when it comes to using existing tools to manage data from a growing number of sources, along with the “system sprawl” that forces users to master multiple applications and manage integrations among those applications.
Read the blogThis industry won't be going back to “the old way.” Oracle GM and SVP, Henry McNamara, makes predictions for sponsors and CROs in 2021.
Read the articleThere’s a reason that you may have seen a dog roaming the halls of your local hospital. Research shows that animals can improve the mental, physical, and emotional wellbeing of their human companions.
Read the blogFinal recommendations on your UX study allow your stakeholders to quickly understand the big takeaway from this project, and take the appropriate actions in response to those findings.
Read the blogHow do you communicate your findings from a UX study so that your stakeholders can actually understand them the way you do, and use them to improve the user experience?
Read the blogHow are organizations approaching the adoption of machine learning capabilities to the planning and execution of clinical trials?
Read the blogStakeholders have been very vocal – there is no turning back – cumulating in the #NoGoingBack movement, arguing that the pace of innovation adoption must continue in a post-COVID-19 world.
Read the blogA recent survey conducted by Oracle reveals trial professionals’ thoughts, feelings and behavior around decentralized research in the face of the pandemic.
Read the articleThe concept of decentralized trials with “hybrid” (in-person and remote patient visits) or fully-remote subject visits has just been catapulted beyond small satellite innovation teams to becoming the new norm.
Read the blogICON discusses the efficiencies gained moving their safety case management to the cloud while maintaining quality and accuracy.
Read the blog76% of industry respondents are now running some decentralized trials, but cite concerns with data collection and quality.
Read the blogWith Oracle’s Clinical One, the problems that were a nightmare in the making are now a thing of the past. With its sleek adaptive trial design, this truly unified platform is a great fit for Health Decisions.
Read the blogMany facets of a clinical trial are unpredictable. This is why scenario planning is so valuable, and critical to helping to manage the variability in clinical trial setup decisions.
Read the blogICH E6 (R2) introduces the concepts of vendor oversight and risk management, but have these requirements been implemented jointly or as separate initiative’s today?
Read the blogAfter recruiting participants for usability testing it's on to discovery, setting up the environment which mirrors what participants see every day and observing them as they navigate a series of tasks to be performed.
Read the blogThe COVID-19 pandemic has changed so many things about our personal and work lives that have us anxious to get back to normal. The pandemic has also led to some significant changes in clinical trials.
Read the blogDiscover how machine learning provides critical operational insights, allowing organizations to learn and adapt.
Read the blogEvery year, the brightest minds in pharmaceuticals and clinical innovation put on their best black-tie attire for the life science industry’s biggest event – the Prix Galien.
Read the blogThe CRO and life sciences tech firm collaborated on a solution capable of meeting challenges tied to starting and conducting global clinical trials.
Read the articleHow have current trends like patient-centric trials been empowering the site landscape, and how has the pandemic helped shape the future of how patient-facing devices are used?
Read the blogAs patient-worn sensors and IoT put more data at the fingertips of investigators, managing that data requires a shift to more modern technology solutions.
Read the blogMachine learning technologies can help predict outcomes in clinical trials, leading to faster drug approval times, lower costs, and more funding to develop new treatments.
Read the blogStudy sponsors and global health organizations can take advantage of Oracle Health Sciences Clinical One cloud platform to improve clinical trial efficiency.
Read the blogFor the thousands of active clinical trials, mitigation plans were set. Clinical development teams needed to assess which trials would need to be delayed, others completely stopped, some prematurely ended.
Read the blogFor the fourth straight year, Oracle Health Sciences has been named a “Leader” in the Everest Group Clinical Development Platforms Products PEAK Matrix® Assessment 2020. Oracle Health Sciences maintained its position as the highest positioned vendor in “Vision and Capability” and took the highest position for “Market Impact.”
Read the blogMachine learning allows organizations to continuously improve with direct implications on timelines and associated costs of clinical trials.
Read the blogThe immediate impact of COVID-19 on clinical trials is now being overshadowed by the opportunities it presents to reimagine and reinvigorate studies.
Read the blogAs the capabilities of various systems improve over time, more widespread use of touchless processing will become feasible. Given that likely future, companies can begin now to plan for and lay the groundwork for a touchless case processing system.
Read the blogDue to an overwhelming response: Q&A follow-up to the inaugural CRO Roundtable.
Read the blogFundamental to ICH guidelines is the modernization of processes and technology to clinical trials with a focus on Quality by Design and risk-based management approaches.
Read the blogWhile simpler automation processes are able to replace routine or static human activity, AI systems are capable of analyzing data and applying specialized knowledge to the safety case process.
Read the blogWhat is drug safety - a critical part of the clinical trial process and post-marketing management of a drug or device? And why is it important?
Read the blogClinical operations staff need to have confidence in machine learning predictive models and be able to validate the accuracy of outcomes.
Read the blogWith more companies responding to growing caseloads by using automation to streamline elements of the pharmacovigilance/multivigilance process, it’s useful for safety professionals to understand the different options available.
Read the blogICH E6(R3) is coming at a time when organizations are struggling to adopt ICH E6(R2). But should organizations wait until these guidelines are ratified to realize the intended benefits?
Read the blogRecruiting participants is arguably the toughest mountain to climb when putting together a usability test. We know who we are looking for, but actually finding them takes it to another level.
Read the blogWhat is biometric monitoring and how can we embrace it in clinical trials? What's the difference between consumer wearables and biometric technology?
Read the blogThe stage is set for those CROs who embrace innovative approaches to overcome adversary, to reap significant benefits now – and in the future.
Read the blogThe gamification of many aspects of our culture is well under way, and some researchers are even beginning to consider the integration of gamification principles into clinical trials.
Read the blogBefore embarking on any usability testing, it’s important to define a roadmap to make sure everyone who’s involved gets the most out of it. Our journey starts with the study protocol.
Read the blogIf all the various tools or applications offered by a vendor are simply 'connected' through APIs...is it really a platform?
Read the blogLearn how FHI Clinical is reimagining the possible with a unified platform for clinical trials to meet the challenges of a global health event.
Read the blogIf you’ve ever known someone who has been in a trial, the whole process is an anxiety-filled duration of time that can lead to happiness, heartbreak, or even confusion. It’s important to recognize their efforts and thank them — but this is often overlooked.
Read the blogNew capability goes beyond EDC to redefine data collection in clinical trials.
Read the blogOracle’s cloud-based data collection solution is designed to help clinical trials better manage multiple sources for greater efficiency and accuracy.
Read the articleOracle Health Sciences has introduced Clinical One Data Collection Cloud Service—with the ability to capture data from any source into a single, unified platform.
Read the articleClinical researchers often struggle to make trials a patient-friendly experience. This makes it more difficult to recruit people for new trials, increase patient-retention, and follow study protocols.
Read the blogWhile subject matter expertise, relationships, and qualifications will always be critical for CRO selection, they are simply not sufficient criteria for sponsors who need to make a step change in efficiency.
Read the blogGain a deeper understanding of the issues and barriers that prevent clinical research from being more efficient and effective in order to help deliver the most value to our customers and the industry.
Read the articleVirtually all leaders believe that to stay competitive, their enterprises must learn and improve every day. In-depth industry experience and a willingness to learn are essential.
Read the blogMay 20 is Clinical Trials Day, a time set aside to celebrate the people who conduct clinical trials, and thank the patients who participate in them. It's a day to acknowledge all those who contribute to improving public health and extending the goals of clinical research.
Read the blogPeachtree BioResearch taps Oracle Health Sciences to streamline operations and boost competitiveness in the initialization of clinical trials.
Read the blogMachine-learning technologies can help predict outcomes in clinical trials, leading to faster drug approval times, lower costs, and more funding to develop new treatments.
Read the blogWeb-based maps offering real-time traffic conditions and route planning provide a fitting analogy to describe the complexity of study startup.
Read the blogBuilding relationships to improve clinical trial operations requires embracing centralized monitoring and study quality metrics as standard practice and, more recently, CRO oversight.
Read the blogVirtual visits and remote patient monitoring provide new options for data collection and are necessities in our current environment.
Read the blogSimply handing off multimillion-dollar studies to CROs without carefully crafted plans for communications and reporting operational data as the study unfolds is hardly a wise move; yet what kind of oversight is needed?
Read the blogStudy startup has surprisingly few guidelines. With limited regulations focused on this early part of clinical trial execution, what does it mean to be compliant?
Read the blogReforecasting clinical trials based on the latest data and information can improve operations and overall trial performance and is a critical component of keeping your company’s plans in line with its financial position and on track to meet its goals.
Read the blogFinding and getting access to clinical trials can be challenging, if not daunting for patients. For those who don’t qualify for a study, but still want to gain access to the medicine, there are a few newer options: compassionate use and right to try.
Read the blogThe focus on technology as a driver of performance improvement in clinical trials is intense, but despite years of valiant efforts, study execution remains far from optimal. For study startup, the data are dismal.
Read the blogWhat exactly do terms like remote, siteless, hybrid, and decentralized trials mean and do for us? In order to work together, we need to better understand each other and what terms help and hinder our progress.
Read the blogSponsors primarily outsource to CROs to control operational and infrastructure costs. Although there are obvious benefits to outsourcing, it creates new challenges around quality, oversight, collaboration, and governance.
Read the blogGranular, real-time metrics provide operational insights, allowing you to take control of your studies by being proactive instead of reactive.
Read the blogThe landscape has been changing rapidly, as patient-facing technologies become more tightly integrated into the clinical trial process.
Read the blogAdvancements in technology have enabled virtual visits and remote patient monitoring, providing new options for data collection.
Read the blogWith unrelenting pressures to rein in budgets and cycle times, stakeholders are turning to quality as a solution, starting with building it into study startup and bringing change to entrenched silos that stall trial operations.
Read the blogThe Association of Clinical Research Organizations (ACRO) provides the forum for leading CROs to collaborate and discuss this rapidly changing world of technology, regulatory requirements /guidance, and industry standards in clinical research.
Read the blogThe capture of big data, as well as a technical ability to analyze it, is frequently referred to as one of the top 10 clinical innovations in the last decade.
Read the blogArtificial Intelligence (AI) can help pharmaceutical companies gather more important data and boost pharmacovigilance.
Read the articleOracle Health Sciences gives PharSafer the ability to optimize management and processing of critical data.
Read the blogUnfortunately, most mass media coverage of clinical trials has been negative and/or unbalanced, focusing largely on risks, human error, and questionable motives.
Read the blogThe hesitancy to change is understandable given the potential impact on an organization. Are decentralized and hybrid trials right for your organization?
Read the blogThe future success of the life science industry in bringing new products to market rests on the ability of sponsors and CROs to work together successfully, providing both parties a compelling incentive to strengthen their partnership with the help of the right structure, tools, and strategies.
Read the blogGlobalization is adding to the complexity of running clinical trials and the pursuit of global trials is increasing.
Read the blogOracle’s participation in The Oppportunity Project (TOP) Technology Spring could help enable the use of open data and AI to match cancer patients with clinical trials and experimental therapies.
Read the blogOracle Health Sciences and the CNS Summit released a research report on the use of virtual components (patient-facing technologies) in clinical trials.
Read the articleCompanies should look to optimize their clinical operations by using monitoring technology, analytical dashboards, and operational metrics to gain powerful insights.
Read the article (PDF)